These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 22155091)

  • 1. Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson's disease.
    Noelker C; Schwake M; Balzer-Geldsetzer M; Bacher M; Popp J; Schlegel J; Eggert K; Oertel WH; Klockgether T; Dodel RC
    Neurosci Lett; 2012 Jan; 507(1):10-5. PubMed ID: 22155091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender segregation in gene expression and vulnerability to oxidative stress induced injury in ventral mesencephalic cultures of dopamine neurons.
    Tao Q; Fan X; Li T; Tang Y; Yang D; Le W
    J Neurosci Res; 2012 Jan; 90(1):167-78. PubMed ID: 21919034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
    Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
    Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
    J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of expression and protein interactions in a 6-hydroxydopamine-induced rat brain lesion model.
    Park B; Yang J; Yun N; Choe KM; Jin BK; Oh YJ
    Neurochem Int; 2010 Aug; 57(1):16-32. PubMed ID: 20403401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the protein disulfide isomerase family member PDIp in experimental Parkinson's disease and Lewy body pathology.
    Conn KJ; Gao W; McKee A; Lan MS; Ullman MD; Eisenhauer PB; Fine RE; Wells JM
    Brain Res; 2004 Oct; 1022(1-2):164-72. PubMed ID: 15353226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson's disease: a post-mortem study in human control subjects.
    Lu L; Neff F; Fischer DA; Henze C; Hirsch EC; Oertel WH; Schlegel J; Hartmann A
    Neurobiol Dis; 2006 Aug; 23(2):409-21. PubMed ID: 16753304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
    Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
    J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes on 5-HT2 receptor mRNAs in striatum and subthalamic nucleus in Parkinson's disease model.
    Zhang X; Andren PE; Svenningsson P
    Physiol Behav; 2007 Sep; 92(1-2):29-33. PubMed ID: 17588622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease.
    Tian YM; Chen X; Luo DZ; Zhang XH; Xue H; Zheng LF; Yang N; Wang XM; Zhu JX
    Neuroscience; 2008 May; 153(3):634-44. PubMed ID: 18420351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase.
    Zhang W; Wang T; Qin L; Gao HM; Wilson B; Ali SF; Zhang W; Hong JS; Liu B
    FASEB J; 2004 Mar; 18(3):589-91. PubMed ID: 14734632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models.
    Kim HG; Ju MS; Shim JS; Kim MC; Lee SH; Huh Y; Kim SY; Oh MS
    Br J Nutr; 2010 Jul; 104(1):8-16. PubMed ID: 20187987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tat-Hsp70 protects dopaminergic neurons in midbrain cultures and in the substantia nigra in models of Parkinson's disease.
    Nagel F; Falkenburger BH; Tönges L; Kowsky S; Pöppelmeyer C; Schulz JB; Bähr M; Dietz GP
    J Neurochem; 2008 May; 105(3):853-64. PubMed ID: 18182047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies.
    Xu L; Sheng J; Tang Z; Wu X; Yu Y; Guo H; Shen Y; Zhou C; Paraoan L; Zhou J
    Neurobiol Dis; 2005 Feb; 18(1):152-65. PubMed ID: 15649706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RA410/Sly1 suppresses MPP+ and 6-hydroxydopamine-induced cell death in SH-SY5Y cells.
    Bando Y; Katayama T; Taniguchi M; Ishibashi T; Matsuo N; Ogawa S; Tohyama M
    Neurobiol Dis; 2005 Feb; 18(1):143-51. PubMed ID: 15649705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease.
    Stichel CC; Schoenebeck B; Foguet M; Siebertz B; Bader V; Zhu XR; Lübbert H
    Eur J Neurosci; 2005 Jan; 21(2):301-16. PubMed ID: 15673431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.
    Shin JY; Park HJ; Ahn YH; Lee PH
    J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.